Morgan Stanley, Polaris
The CEO also said he is ‘bullish’ on the potential for stock sales, including initial public offerings in 2025.
Morgan Stanley analyst Terence Flynn maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,185.00.
Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...
Shares of cosmetics company e.l.f. Beauty (NYSE:ELF) fell 5.9% in the afternoon session after research by Morgan Stanley ...
Robinhood Markets (NASDAQ:HOOD) shares gained 3.8% in Friday morning trading after Morgan Stanley Research moved the Overweight-rated retail trading app to top pick, owing to "many vectors for ...
With a TikTok ban potentially set to take effect in the U.S. on Sunday, other social media platforms could compete for its ...
Hosted on MSN6h
Morgan Stanley Upgrades Qorvo (QRVO)Fintel reports that on January 21, 2025, Morgan Stanley upgraded their outlook for Qorvo (NasdaqGS:QRVO) from Equal-Weight to ...
The investment banking giant has been the subject of regulatory probes regarding the way it vets prospective clients. So far, ...
Profits at Bank of America (BAC) and Morgan Stanley (MS) more than doubled in the fourth quarter, signaling a strong 2024 for ...
Wynn Resorts, Limited (WYNN) stock saw a modest uptick, ending the day at $84.67 which represents a slight increase of $2.17 or 2.63% from the prior close of $82.5. The stock opened at $83.25 and ...
Q4 earnings season has the potential to reveal actual progress and results for freight transportation companies, according to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback